Showing results (51-60 of 90) with videos related to

Sort By:
Pageof 9
Acta Ophthalmologica Scandinavica|February 26, 2004
Efficacy and tolerability of the dorzolamide 2%/timolol 0.5% combination (COSOPT) versus 0.005% (XALATAN) in the treatment of ocular hypertension or glaucoma: results from two randomized clinical trialsRobert D Fechtner, P Juhani Airaksinen, Albert J Getson, et al.
Antonie Van Leeuwenhoek|January 1, 1979
Colonization by Salmonella typhimurium and Shigella flexneri III of the gastrointestinal tract of mice treated with beta-2-thienylalanine and streptomycinK J Brown, G W Tannock, R A Eyres, et al.
Plos One|March 2, 2013
Patterns and drivers of tree mortality in iberian forests: climatic effects are modified by competitionPaloma Ruiz-Benito, Emily R Lines, Lorena Gómez-Aparicio, et al.
Cephalalgia : an International Journal of Headache|February 13, 2009
Age effects on placebo response rates in clinical trials of acute agents for migraine: pooled analysis of rizatriptan trials in adultsT W Ho, X Fan, A Rodgers, et al.
Headache|January 24, 2009
Ten years of rizatriptan: from development to clinical science and future directionsRichard J Hargreaves, Chris R Lines, Alan M Rapoport, et al.
Global Change Biology|April 29, 2014
Wood production response to climate change will depend critically on forest composition and structureDavid A Coomes, Olivier Flores, Robert Holdaway, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 7, 2017
Telomere length in patients with pulmonary fibrosis associated with chronic lung allograft dysfunction and post-lung transplantation survivalChad A Newton, Julia Kozlitina, Jefferson R Lines, et al.
Psychopharmacology|January 1, 1989
Scopolamine and benzodiazepine models of dementia: cross-reversals by Ro 15-1788 and physostigmineG C Preston, C Ward, C R Lines, et al.
Peerj|February 13, 2016
Can we set a global threshold age to define mature forests?Philip Martin, Martin Jung, Francis Q Brearley, et al.
Alimentary Pharmacology & Therapeutics|January 3, 2001
Review article: the gastrointestinal safety profile of rofecoxib, a highly selective inhibitor of cyclooxygenase-2, in humansC J Hawkey, L Jackson, S E Harper, et al.
Pageof 9